Systemic telomere length and preclinical atherosclerosis: the Asklepios Study
- PMID: 19687155
- DOI: 10.1093/eurheartj/ehp324
Systemic telomere length and preclinical atherosclerosis: the Asklepios Study
Abstract
Aims: Peripheral blood leucocyte (PBL) telomere length (TL) is a systemic ageing biomarker and has been proposed to be an independent predictor of cardiovascular disease (CVD). We aimed at providing an explanation for this association by the evaluation of the biomarker value of PBL-TL in preclinical atherosclerosis.
Methods and results: Peripheral blood leucocyte telomere length was assessed by telomere restriction fragment analysis in 2509 volunteers free from established CVD, aged approximately 35-55 years old, from the Asklepios Study cohort. Intima-media thickness (IMT) and plaque presence were determined by ultrasonography in both left and right carotid and femoral arteries. Peripheral blood leucocyte telomere length was not a significant independent determinant of IMT (P > 0.3) or plaque presence (P > 0.05), in either artery or either sex. In women but not in men, PBL-TL was a weak determinant of combined (carotid or femoral) plaque presence, adjusted for other risk factors (women: P = 0.03, men: P > 0.4). However, even in women presenting plaques, PBL-TL was still longer than in men.
Conclusion: Since systemic TL is not a substantial underlying determinant of preclinical atherosclerosis, the association between CVD and TL cannot be explained by the fact that subjects with shorter inherited TL are predisposed to atherosclerosis.
Similar articles
-
Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease.Aging Cell. 2007 Oct;6(5):639-47. doi: 10.1111/j.1474-9726.2007.00321.x. Aging Cell. 2007. PMID: 17874998
-
Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk.Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1649-56. doi: 10.1161/ATVBAHA.110.205492. Epub 2010 May 27. Arterioscler Thromb Vasc Biol. 2010. PMID: 20508208
-
Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA Study.J Am Coll Cardiol. 2016 May 31;67(21):2467-76. doi: 10.1016/j.jacc.2016.03.530. J Am Coll Cardiol. 2016. PMID: 27230041
-
No shorter telomeres in subjects with a family history of cardiovascular disease in the Asklepios study.Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3076-81. doi: 10.1161/ATVBAHA.112.300341. Epub 2012 Oct 18. Arterioscler Thromb Vasc Biol. 2012. PMID: 23087363
-
Telomere length as a biological marker in malignancy.Biochim Biophys Acta. 2009 Apr;1792(4):317-23. doi: 10.1016/j.bbadis.2009.01.017. Epub 2009 Feb 7. Biochim Biophys Acta. 2009. PMID: 19419696 Review.
Cited by
-
Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies.Am J Clin Nutr. 2018 Sep 1;108(3):453-475. doi: 10.1093/ajcn/nqy107. Am J Clin Nutr. 2018. PMID: 30535086 Free PMC article.
-
Telomeres and atherosclerosis.Cardiovasc J Afr. 2012 Nov;23(10):563-71. doi: 10.5830/CVJA-2012-056. Cardiovasc J Afr. 2012. PMID: 23192261 Free PMC article. Review.
-
On cross-sectional associations of leukocyte telomere length with cardiac systolic, diastolic and vascular function: the Asklepios study.PLoS One. 2014 Dec 15;9(12):e115071. doi: 10.1371/journal.pone.0115071. eCollection 2014. PLoS One. 2014. PMID: 25506937 Free PMC article.
-
Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes.Circ Res. 2017 Mar 31;120(7):1130-1138. doi: 10.1161/CIRCRESAHA.116.309421. Epub 2016 Dec 12. Circ Res. 2017. PMID: 27956416 Free PMC article.
-
Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: the Strong Heart Family Study.Aging (Albany NY). 2014 May;6(5):414-27. doi: 10.18632/aging.100671. Aging (Albany NY). 2014. PMID: 24902894 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical